3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

M. Segura, J. Ortuño, M. Farré, J. A. Mc Lure, M. Pujadas, N. Pizarro, A. Llebaria, J. Joglar, P. N. Roset, J. Segura, R. De la Torre

Research output: Contribution to journalArticleResearchpeer-review

97 Citations (Scopus)

Abstract

There is evidence that some heavy users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) show signs of neurotoxicity (a cognitive dysfunction, a larger incidence of psychopathology). It has been postulated that the catechol intermediates of methylenedioxyamphetamines such as 3,4-dihydroxymethamphetamine (HHMA), a metabolite of MDMA, may play a role in their neurotoxicity by formation of thioether adducts. This study describes the first validated method for HHMA determination in plasma and urine by strong cation-exchange solid-phase extraction high-performance liquid chromatography/electrochemical detection (HPLC/ED) analysis. The method has been applied for the determination of HHMA in plasma and urine samples from a clinical study in healthy volunteers of MDMA and provides preliminary kinetic data on this metabolite. HHMA appeared to be a major MDMA metabolite with plasma concentrations as high as the parent compound. Thus, HHMA Cmax (154.5 μg/L) and AUC0-24h(1990.9 μg/L h) were similar to those obtained in previously published reports for MDMA (181.6 μg/L and 1465.9 μg/L h, respectively). The 24-h urinary recovery of HHMA accounted for 17.7% of the MDMA dose administered and increases the total 24 h recovery of MDMA and metabolites to 58% of the 100 mg dose administered. The determination of HHMA in plasma and urine samples is of interest in order to establish its relevance in MDMA metabolism and its possible contribution to MDMA neurotoxicity in humans. Its validation showed appropriate accuracy and precision for its use in pharmacokinetic studies.
Original languageEnglish
Pages (from-to)1203-1208
JournalChemical Research in Toxicology
Volume14
DOIs
Publication statusPublished - 10 Oct 2001

Fingerprint

Dive into the research topics of '3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans'. Together they form a unique fingerprint.

Cite this